Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes

Clinical Cancer Research

Volumn 11, Issue 15, 2005, Pages 5425-5432

  Ulmer, Anja ^a   Fischer, Jörg R ^b   Schanz, Stefan ^a   Sotlar, Karl ^c   Breuninger, Helmut ^a   Dietz, Klaus ^c   Fierlbeck, Gerhard ^a   Klein, Christoph A ^b,d  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Institut für Immunologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY HMB 45;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE;

EID: 23044517396     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1995     Document Type: Article

References (19)

1. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48.
2. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, Steiniche T. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004;100:1683-91.
3. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003;200:314-9.
4. Gogel BM, Kühn JA, Ferry KM, et al. Sentinel lymph node biopsy for melanoma. Am J Surg 1998;176;544-7.
5. Yu LL, Flotte TJ, Janabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617-27.
6. Gietema HA, Vuylsteke RJ, de Jonge IA, et al. Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2004;57:618-20.
7. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 1999;52:871-3.
8. Bieligk SC, Ghossein R, Bhattacharya S, Coit DG. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 1999;6:232-40.
9. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.
10. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999;96:4494-9.
11. Ulmer A, Schmidt-Kittler O, Fischer J, et al. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin Cancer Res 2004;10:531-7.
12. Lawrence WD. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch 2001;439:601-3.
13. Baisden BL, Askin FB, Lange JR, Westra WH. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with metanoma. Am J Surg Pathol 2000;24:1140-6.
14. Scolyer RA, Thompson JF, McCarthy SW. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004;101:2141-2; author reply 2142-3.
15. Kammula US, Ghossein R, Bhattacharya S, Coit DG. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction - staged sentinel lymph nodes from melanoma patients. J Clin Oncol 2004;22:3989-96.
16. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998;58:2170-5.
17. Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997;57:2765-80.
18. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 2003;100:7737-42.
19. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003;163:1765-70.